Commercial A year after Vertex’s big launch, pain drug research faces a pivotal moment BioPharma DiveJournavx revived an area of development long considered a graveyard.Pain & AnaesthesiaRead full story pharminent May 12, 2026 (Last updated: May 16, 2026) BioPharma Dive Journavx revived an area of development long considered a graveyard. Pain & Anaesthesia Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: FDA weighs drug repurposing pathway for underserved diseasesNext: Novo says high-dose Wegovy can cause 28% weight loss Related Stories Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management pharminent July 6, 2026 Commercial Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval pharminent June 26, 2026 Commercial Lilly launches its LillyDirect sales channel in the UK pharminent June 25, 2026
